News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Daily News Getting Ready for a Heart Failure Polypill, Well Before the Data Are In Todd Neale October 16, 2025
News Daily News ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care Todd Neale December 11, 2024
News Conference News AHA 2024 REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients L.A. McKeown November 22, 2024
News Daily News Yes, Clinical Inertia IS the Leading Cause of GDMT Underuse in HFrEF Todd Neale September 20, 2024
News Daily News Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors Yael L. Maxwell August 15, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Conference News ESC Heart Failure 2022 Dapagliflozin Boosts Health Status Across LVEF Range Shelley Wood May 23, 2022
News Daily News One in Six HF Patients Delay or Forego Care, Inflating Costs Shelley Wood August 12, 2021
News Features Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic Yael L. Maxwell March 24, 2020
News Daily News TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State Michael O'Riordan January 22, 2020
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities Todd Neale March 06, 2018
News Daily News With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year Michael H. Wilson June 28, 2016